Jinyu Bio-Technology Co Ltd Asset Resilience Ratio

Latest as of June 2026: 0.92%

Jinyu Bio-Technology Co Ltd asset resilience ratio. Jinyu Bio-Technology Co Ltd (600201) has an Asset Resilience Ratio of 0.92% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jinyu Bio-Technology Co Ltd (600201) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥61.15 Million
≈ $8.95 Million USD Cash + Short-term Investments

Total Assets

CN¥6.62 Billion
≈ $968.24 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Jinyu Bio-Technology Co Ltd (2016–2025)

Asset resilience ratio of Jinyu Bio-Technology Co Ltd from 2016 to 2025. This chart shows how Jinyu Bio-Technology Co Ltd's Asset Resilience Ratio has changed over time. Read Jinyu Bio-Technology Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jinyu Bio-Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 600201 asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥61.15 Million 0.92%
Total Liquid Assets CN¥61.15 Million 0.92%

Asset Resilience Insights

  • Limited Liquidity: Jinyu Bio-Technology Co Ltd maintains only 0.92% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jinyu Bio-Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jinyu Bio-Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Samsung Biologics Co Ltd
KO:207940
Biotechnology 15.21%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821
Biotechnology 5.07%
Immunovant Inc
NASDAQ:IMVT
Biotechnology 98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
Biotechnology 21.11%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Amicus Therapeutics Inc
NASDAQ:FOLD
Biotechnology 8.37%

Jinyu Bio-Technology Co Ltd Asset Resilience Ratio by Year (2016–2025)

Jinyu Bio-Technology Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Jinyu Bio-Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.82% CN¥120.11 Million
≈ $17.58 Million
CN¥6.61 Billion
≈ $967.48 Million
+1.27pp
2024-12-31 0.54% CN¥36.83 Million
≈ $5.39 Million
CN¥6.76 Billion
≈ $989.88 Million
+0.00pp
2023-12-31 0.54% CN¥37.27 Million
≈ $5.45 Million
CN¥6.87 Billion
≈ $1.01 Billion
-0.19pp
2022-12-31 0.73% CN¥46.94 Million
≈ $6.87 Million
CN¥6.39 Billion
≈ $934.96 Million
-2.05pp
2021-12-31 2.78% CN¥183.85 Million
≈ $26.90 Million
CN¥6.60 Billion
≈ $966.36 Million
-7.40pp
2020-12-31 10.19% CN¥639.48 Million
≈ $93.58 Million
CN¥6.28 Billion
≈ $918.71 Million
-1.85pp
2019-12-31 12.04% CN¥672.48 Million
≈ $98.40 Million
CN¥5.59 Billion
≈ $817.39 Million
-0.63pp
2018-12-31 12.67% CN¥800.00 Million
≈ $117.07 Million
CN¥6.31 Billion
≈ $923.82 Million
-1.40pp
2017-12-31 14.08% CN¥800.00 Million
≈ $117.07 Million
CN¥5.68 Billion
≈ $831.69 Million
+8.05pp
2016-12-31 6.03% CN¥262.00 Million
≈ $38.34 Million
CN¥4.35 Billion
≈ $636.21 Million
--
pp = percentage points

About Jinyu Bio-Technology Co Ltd

SHG:600201 China Biotechnology
Market Cap
$2.01 Billion
CN¥13.72 Billion CNY
Market Cap Rank
#5931 Global
#1093 in China
Share Price
CN¥12.47
Change (1 day)
-1.03%
52-Week Range
CN¥10.50 - CN¥18.78
All Time High
CN¥30.02
About

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary biological products in China and internationally. The company's products focus on preventing porcine mycoplasmal pneumonia, pseudorabies, highly pathogenic avian influenza, brucellosis, and other Class I, II, and III animal diseases. It also provides pig vaccines, swine foot-and-mouth diseas… Read more